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Purpose: To compare the choroidal thickness among eyes with retinitis pigmentosa (RP),
Stargardt disease, Usher syndrome, cone-rod dystrophy, and healthy eyes of sex- and
age-matched individuals.
Methods: In this comparative study, 503 eyes with RP (n = 264), cone-rod dystrophy
(n = 109), Stargardt disease (n = 76), and Usher syndrome (n = 54) were included. To
validate the data, 109 healthy eyes of 56 sex- and age-matched individuals were studied
as controls. Choroidal imaging was performed using enhanced depth imaging-optical
coherence tomography. Choroidal thickness was measured manually using MATLAB
software at 13 points in nasal and temporal directions from the foveal center with the
interval of 500 µm and the choroidal area encompassing the measured points was
calculated automatically.
Results: The mean age was 36.33 ± 13.07 years (range, 5 to 72 years). The mean
choroidal thickness at 13 points of the control eyes was statistically significantly higher
than that in eyes with RP (P < 0.001) and Usher syndrome (P < 0.05), but not significantly
different from that in eyes with Stargardt disease and cone-rod dystrophy. Among
different inherited retinal dystrophies (IRDs), the choroidal thickness was the lowest in
eyes with RP (P < 0.001). Choroidal thickness in the subfoveal area correlated negatively
with best-corrected visual acuity (r = −0.264, P < 0.001) and the duration of ocular
symptoms (r = −0.341, P < 0.001) in all studied IRDs. No significant correlation was
observed between the subfoveal choroidal thickness and central macular thickness (r
= −0.24, P = 0.576).
Conclusion: Choroidal thinning in four different types of IRDs does not follow a similar
pattern and depends on the type of IRD and the duration of ocular symptoms. A larger
cohort is required to verify these findings.
Keywords: Choroidal Thickness; Cone-rod Dystrophy; Enhanced Depth Optical Coherence
Tomography; Inherited Retinal Dystrophy; Retinitis Pigmentosa; Stargardt Disease; Usher
Syndrome
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INTRODUCTION
Photoreceptors and retinal pigment epithelial (RPE)
cells as their protectors are the primary units
for light photon translation into neural electric
codes.[1] Choroid is a complex vascular tissue
that supplies oxygen and nutrients to these
cells with a high metabolism rate. Therefore,
a healthy choroidal vasculature could provide
optimum blood flow to RPE and photoreceptor
cells.[2] Inherited retinal dystrophies (IRDs) are
ocular diseases that primarily involve progressive
degeneration of RPE and/or photoreceptor cells.[3]
Retinitis pigmentosa (RP) is the most prevalent
type of IRD that has been estimated to affect
approximately 1.5 million individuals worldwide.[4]
Stargardt disease is the most prevalent inherited
macular dystrophy with an estimated prevalence
of 1 per 10,000 individuals.[5] A recent study
showed that mutations in more than 120 causative
genes are responsible for different types of IRDs[6]
and these mutations can be transmitted to the
next generation by different Mendelian patterns
of inheritance.[7] Generally, it appears that the
outer retina and RPE cells are primarily involved,
resulting in death of these cells.[8, 9] Choriocapillaris
may also be involved in the late stages of the
disease, manifesting as chorioretinal atrophy in
fundus examination.[9, 10]
Currently, there is no definite treatment for
IRDs. However, recent advances have been
reported in the field of gene therapy for RP, Leber’s
congenital amaurosis, and Stargardt disease.[11]
If gene therapy may be speculated to repair the
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defect in gene function, healthy choriocapillaries
are necessary to provide enough blood flow to
compensate for the normal metabolic needs of the
outer retina.
Enhanced depth imaging (EDI) by spectral
domain optical coherence tomography (SD-OCT),
is a technique used to visualize the detailed
structure of the choroidal tissue from the nasal
region adjacent to the optic nerve to the subfoveal
choroid and the temporal region of the choroid and
can be used to measure the choroidal thickness.[12]
Measurement of the choroidal thickness can be
informative in determining the pathophysiology
and natural course of IRDs.[13–15]
Some studies have reported a significant
reduction in the choroidal thickness in RP,[4, 15, 16]
Stargardt disease,[17] and cone dystrophy[18] when
compared with healthy controls. However, no
difference was observed in other studies.[5, 19] Due
to this discrepancy, the aim of the present study
was to measure the choroidal thickness in a large
Iranian cohort with RP, Stargardt disease, cone-rod
dystrophy, and Usher syndrome and to compare
it with age-matched healthy subjects using EDI-
optical coherence tomography (EDI-OCT). The
study also aimed to evaluate the relationship of
choroidal thickness with the best-corrected visual
acuity (BCVA), central macular thickness (CMT),
and the duration of ocular symptoms.
METHODS
In this comparative study, 503 eyes of 253 patients
diagnosed with IRDs including RP (264 eyes of
133 patients), Stargardt disease (76 eyes of 38
patients), cone-rod dystrophy (109 of 55 patients),
and Usher syndrome (54 eyes of 27 patients) were
included. For comparison, 109 normal eyes of 56
healthy subjects were included as controls. Healthy
controls were matched based on patients’ age and
sex. Data were extracted from the Iranian National
Registry of IRDs (IRDReg®). Patients were recalled
for additional examinations and imaging according
to the standard protocol. This study was conducted
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at Labbafinejad Medical Center, Tehran, Iran, from
January 2016 to August 2018.
The Ethics Committee of the Ophthalmic
Research Center, Research Institute for
Ophthalmology and Vision Science, Shahid
Beheshti University of Medical Sciences, Tehran,
Iran approved this study and all procedures were
in compliance with the tenets of the Declaration of
Helsinki. Written informed consent was obtained
from all subjects for diagnostic procedures and
choroidal imaging.
Visual and Ocular Examinations
Initially, all patients were interviewed to identify the
age of disease manifestations and the common
signs and symptoms including photophobia,
color vision deficiency, nyctalopia, nystagmus,
restricted visual field, and previous general
and ocular conditions. All subjects underwent
complete ophthalmic examination including
BCVA assessment, color vision testing using
Ishihara Pseudoisochromatic plates, slit-lamp
biomicroscopy, measurement of the intraocular
pressure using the Goldmann applanation
tonometer, and dilated fundus examination
using a +78D lens. In addition, visual field
testing was performed with Humphrey visual
field (Carl Zeiss Meditec Inc., Dublin, CA, USA)
using 30-2 Swedish Interactive Threshold
Algorithm standard method. Additionally, SD-
OCT scanning was performed and choroidal
thickness was also measured using the EDI-
OCT scan (Spectralis, Heidelberg Engineering,
Heidelberg, Germany). Fundus photographs
were obtained by a digital stereoscopic
camera (Visucam Pro NM, Carl Zeiss Meditec
AG, Germany). Infrared imaging, fundus
autofluorescence, and fluorescein angiography
(Heidelberg Engineering GmbH, Heidelberg,
Germany) were also performed. In addition,
electrophysiological examinations including
electroretinography (ERG) and/or electro-
oculography (RETIport 21 system, version 7/03,
Roland Consult, Osaka, Japan) were conducted
to confirm the clinical diagnosis. Based on
fundus examination, macular involvement
was defined as the presence of any kind
of macular abnormality from reduced foveal
reflex to bull’s eye pattern or beaten bronze
appearance.
Inclusion and Exclusion Criteria
Patients with syndromic RP, IRD cases having optic
atrophy due to other etiologies, visually significant
cataract or other media opacities, high refractive
errors (myopia ≥ 5.00 D, hyperopia ≥ 3.00 D, and
astigmatism ≥ 3.00 D), nystagmus or wandering
gaze, poor image quality, and any other associated
retinal pathologies were excluded. Patients with
cystoid macular edema were also excluded from
the analysis. We also excluded patients with
systemic diseases affecting the choroidal thickness
such as systemic hypertension, diabetes, and renal
failure. The control group included sex- and age-
matched healthy subjects with no ocular and
systemic diseases and without high refractive
errors. None of the controls had a positive family
history of IRDs.
Final Diagnosis
The Final diagnosis of retinal dystrophy was
obtained based on clinical examinations, retinal
multimodal imaging, and psychophysical tests such
as ERG, color vision, and visual fields. Additionally,
retinal dystrophywas confirmedby genetic findings
in 98 patients (19.5%). Cross-validation of patients’
response with clinical records was performed to
increase the data validity.
Choroidal Thickness Measurement
Each patient underwent an EDI-OCT scan after
dilation of the pupil by 1% tropicamide eye drop
(Figure 1, A1 to F2). EDI-OCT automatically sets
the choroid closer to the zero-delay line and
thus, theoretically provides better visualization
of the choroidoscleral interface. One horizontal
9mm high-quality line scan through the fovea was
obtained for each eye. The line scan was saved for
analysis after averaging of 100 frames. Choroidal
measurements were performed using MATLAB
2016b program (MathWorks, Natick, MA, USA) at
13 points subfoveally and in nasal and temporal
directions with the interval of 500 µm in a length
of 6000 µm (Figure 1, B1 and B2).
All choroidal measurements were done by
an ophthalmologist familiar with the MATLAB
program. All measurements were performed from
the outer portion of the hyper-reflective line
corresponding to the RPE cells-Bruch’s membrane
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Figure 1. Representative enhanced depth imaging (EDI) of four different inherited retinal dystrophies and of a healthy control.
A1: Right eye of a healthy control, A2: left eye of a healthy control
B1, B2: Examples of choroidal thickness measurement manually and automatically in the right and the left eyes, respectively, of a
healthy subject
C1, C2: EDI of the right and the left eyes, respectively, of a patient with retinitis pigmentosa D1, D2: EDI of the right and the left
eyes, respectively, of a patient with Usher syndrome
E1, E2: EDI of the right and the left eyes, respectively, of a patient with Stargardt disease
F1, F2: EDI of the right and the left eyes, respectively, of a patient with cone-rod dystrophy
Figure 2.Mean choroidal thickness in the subfoveal area and at six different spots along the nasal and the temporal directions in
different types of inherited retinal dystrophies.
RP, retinitis pigmentosa
complex as the inner border to the hypo-reflective
line corresponding to the sclerochoroidal interface
as the outer border. Subsequently, the program
automatically measured choroidal thickness in
the specified spots according to the spaces
defined in the preceding step, measured the
area of choroid in the specified region, and
provided the information in an excel file. The
aforementioned application was designed to work
as follows.
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Figure 3. Mean total choroidal thickness (at 13 spots of measurement) in different types of inherited retinal dystrophies.
RP, retinitis pigmentosa
*Significant P-values between 0.01 and 0.05; ***Significant P-values < 0.001
Figure 4. Mean choroidal area in different types of inherited retinal dystrophies
RP, retinitis pigmentosa
**Significant P-values between 0.01 and 0.001
***Significant P-values < 0.001
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1. An EDI-OCT image was displayed in
a window after loading the image into the
application. The coordinates of all pixels
and their intensities were shown in the
image.
2. The program allowed the physicians
to manually select the center of macula
and the choroidal region on the EDI-OCT
images.
3. Based on the specified center and the
area, six points with 500 μm intervals on each
side of the center (13 points including the
center) were automatically marked and the
choroidal thickness was calculated at these
points.
4. The program also provided charts related
to changes in the choroidal thickness and other
additional information including the area of the
choroidal region.
All EDI-OCT images from the patients
and the controls were obtained from 2:00
to 6:00 pm to reduce the possible effect
of diurnal variation on choroidal thickness.
Finally, two other board-certified retina
specialists independently rechecked the
measurements to avoid disagreements
(Cronbach’s 𝛼 = 0.794). In a few images with
disagreement, the RPE-Bruch’s membrane
complex and the sclerochoroidal interface
were rechecked and the measurements were
repeated to be confirmed by the two retina
specialists.
Statistical Analysis
Data were presented as mean and standard
deviation, median and range, and frequency
and percentage. To compare the subject
characteristics between the IRD and the
control groups, we used Dunnet’s correction for
multiple comparisons. To determine the possible
correlation of the patients’ characteristics or the
IRD characteristics with the choroidal thickness
and the choroidal area, generalized estimating
equation analysis was used. All statistical analyses
were performed using IBM SPSS Statistics for
Windows, version 25.0. (IBM Corp., Armonk,
NY, USA). All tests were two-sided and a P-
values < 0.05 were considered statistically
significant.
RESULTS
In this comparative study, 503 eyes with a
confirmed diagnosis of IRD including three types
of diffuse photoreceptor dystrophies (RP, Usher
syndrome, and cone-rod dystrophy) and one
macular dystrophy (Stargardt disease) were
included. The age and gender distribution of the
patients and controls are presented in Table 1.
We observed that for most of the cases, the
duration since first recognition of the disease
was 10 to 20 years (30.5%, P = 0.04). The
distribution of the IRD duration in 10-year periods
was not significantly different among the types of
IRDs.
Table 2 summarizes the clinical characteristics
of the study subjects. Comparison of central
vision among different types of IRDs showed
that the mean BCVA of patients with cone-
rod dystrophy was significantly lower than
that of patients with Stargardt disease
(P = 0.009) and Usher syndrome (P <
0.001).
The mean CMT values of patients with Stargardt
disease and cone-rod dystrophy were significantly
lower than those of patients from other groups (P <
0.001).
Figure 2 shows the linear comparison of
mean choroidal thickness at each of the 13
different spots in different IRDs and the mean
choroidal thickness in the control group. The
mean subfoveal choroidal thickness in healthy
controls (336.79 ± 82.75 µm) was greater
than that in RP patients (P < 0.001), but did
not differ significantly from mean subfoveal
choroidal thickness in other IRDs including Usher
syndrome, cone-rod dystrophy, and Stargardt
disease.
The mean total choroidal thickness (mean
choroidal thickness at 13 points) in eyes with RP
(P < 0.001) and Usher syndrome (P = 0.042)
was significantly lower than that in healthy
eyes. There was no significant difference
in mean total choroidal thickness between
patients with Stargardt disease and cone-
rod dystrophy vs. healthy controls (P = NS).
The mean choroidal thickness in RP patients
was less than that in patients with Stargardt
disease (P < 0.001), cone-rod dystrophy (P <
0.001), and Usher syndrome (P = 0.028) (Figure
3).
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The mean total choroidal area in different types
of IRD and in healthy controls is illustrated in Figure
4. Themean total choroidal area in healthy subjects
(1.9± 0.4 µm2) was significantly more than that in RP
(1.4 ± 0.5 µm2, P < 0.001) and Usher syndrome (1.6
± 0.5 µm2, P = 0.006). Among different IRDs, the
mean total choroidal area was less in RP patients
than in patients with Stargardt disease (P < 0.001)
and cone-rod dystrophy (P < 0.001).
Additionally, the subfoveal choroidal thickness
was inversely correlated with BCVA (r = −0.264,
P < 0.001) and the duration of ocular symptoms
(r = −0.341, P < 0.001) in all IRDs. However, no
statistically significant correlation was observed
between the subfoveal choroidal thickness and
CMT (r = −0.24, P = 0.576) in all IRDs.
DISCUSSION
In the present comparative study, choroidal
thickness was measured in a large group of
patients with different types of IRDs including RP,
Stargardt disease, Usher syndrome, and cone-rod
dystrophy. We included age- and sex-matched
controls for comparison.
The mean choroidal thickness measured at 13
different spots in the nasal and in the temporal
direction was significantly lower in patients with RP
and Usher syndrome when compared with healthy
controls and patients with Statgardt disease and
cone-rod dystrophy. Other studies have also
reported similar findings.[4, 5, 13, 16] However, no
significant reduction in choroidal thickness was
reported in RP patients in the study by Chhablani
et al.[19] This discrepancy could be attributed to
the different characteristics of the study population
including better BCVA (0.99 ± 0.94 LogMAR)
and younger age (31.09 ± 13.40 years) than
the BCVA (1.19 ± 0.98 LogMAR) and age (40.21
± 13.03 years) of patients in our study. High
number of patients with RP (n = 264) was a
strength of the present study. The number of RP
patients was higher than those included in previous
studies.[4, 13, 16, 19] Sodi et al reported findings
consistent with our results with no difference
in mean choroidal thickness between healthy
controls and patients with Stargardt disease.[5]
They described a statistically significant correlation
between lower subfoveal choroidal thickness and
longer duration of ocular symptoms; this finding
was also observed in the current study.[5]
To the best of our knowledge, this is the first
study that compared the choroidal thickness
among different types of IRDs. Our investigation
showed that the lowest choroidal thickness was
observed in patients with RP. This finding could be
explained by the possible trophic role of RPE cells,
which support proper choroidal function through
secretion of growth factors. Conversely, the
reduction in oxygen demand of the degenerating
photoreceptors will subsequently result in reduced
blood flow to the retina and the choroid, which
is called primary vascular dysregulation in RP
patients.[20, 21] Additionally, RP has been associated
with an imbalance in oxidant/antioxidant status
and subclinical inflammatory processes that may
stimulate the excessive production of endothelin-1
(ET-1).[16, 19] Therefore, retinal degeneration and
choroidal thinning in patients with RP seem to
interact with each other.
The difference in the amount of choroidal
thinning between RP and other IRDs can be
explained by the pathogenesis of RP.[16] Most
of the mutations in RP are attributed to gene
coding of proteins involved in the vision cycle at
the level of photoreceptors and RPE cells. These
mutations cause apoptosis and degeneration
of photoreceptors and subsequent outer retinal
thinning.[16, 22] Photoreceptor atrophy results
in reduced oxygen demand and blood flow.
Furthermore, trophic role of RPE cells through
secretion of growth factors such as vascular
endothelial growth factor[23] that support proper
choroidal function is diminished. Thus, choroidal
thinning can be explained by reduced blood flow
and RPE cell degeneration.
Yoshida et al observed cell, flare, and
inflammatory cytokines in aqueous humor and
vitreous fluid of patients with RP.[24] Confirmation
of reduced level of antioxidants in this group
of patients by Martinez et al is suggestive of
the oxidative stress in RP.[25] Subclinical ocular
inflammatory process and hypoxic-oxidative
stress elicit increased ocular and plasma levels of
ET-1.[16, 22]
ET-1 is the most powerful endogenous
vasoconstrictor of small and large vessels. In
the eye, its synthesis and secretion is performed
by different tissues such as cornea, uveal tissue,
retinal microvascular pericytes, RPE cells, and optic
nerve. Increased levels of ET-1 and vasoconstriction
effect result in vascular dysgenesis and impaired
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ocular blood flow. This vicious cycle contributes
to the amplification of the inflammatory response,
altered intraocular perfusion, relative ischemia,
and consequent degeneration of outer retinal layer
and choroidal thinning.[22]
In the present study, a negative correlation
was observed between the subfoveal choroidal
thickness and BCVA and between subfoveal
choroidal thickness and disease duration of the
IRDs. However, no correlation was observed
between CMT and choroidal thickness. Some
studies have reported a correlation between
choroidal thickness and BCVA and between
choroidal thickness and the duration of ocular
symptoms in IRDs including RP and Stargardt
disease.[4, 5, 19] However, other studies did not find
such correlations.[10, 13, 16, 18] This difference may
be due to a higher number of subjects and a
longer duration of ocular symptoms in the present
study. Ayton et al[4] reported that choroid becomes
thinner with increasing duration of RP symptoms,
which is consistent with the findings of the present
study. However, Sodi et al[16] claimed that age
might have more effect on choroidal thickness than
the duration of RP itself. They suggested that this
lack of association might be due to a very strict
criterion for the definition of age at the onset of
the disease. In the present study, additional age-
adjusted analysis confirmed that age could not be
a confounding variable and the findings may be
directly related to the IRD entity.
Previous studies have found a significant
correlation between CMT and choroidal thickness
in Stargardt disease[5] and no relationship between
them in RP patients.[13, 16, 19] In the present study
with a larger sample size, no correlation was
observed between CMT and subfoveal choroidal
thickness in RP and in Stargardt disease. As
previously stated, patients with cystoid macular
edema were not included in the statistical analysis.
Total choroidal area in the eyes of healthy
subjects was significantly higher than that in eyes
of patients with RP and Usher syndrome. The
choroid was generally thinner in RP patients when
compared with patients having Stargardt disease
and cone-rod dystrophy.
One of the strengths of the present study is
the comparison of choroidal thickness among four
relatively common types of IRDs including RP,
Stargardt disease, Usher syndrome, and cone-
rod dystrophy. Additionally, a larger sample size
compared to the sample size in previous studies is
another merit of this study. The design of the novel
software using MATLAB computer programming
for automatic measurement of the choroidal
parameters minimizes the chance of inter-operator
and intra-operator errors. The measurement of
the total choroidal area as well as the choroidal
thickness at 13 different spots (including the center
of the fovea) 6000 µm along the nasal and the
temporal directions from the center of the fovea is
another merit of the present study.
The present study has some limitations including
the lack of accessibility to the genetic data for
all study subjects. Another limitation of this study
was relying on patients’ self-report for identification
of the age of disease onset. Of course, cross-
validation of patients’ responsewith clinical records
was performed to increase the data validity.
In conclusion, with the same duration of ocular
symptoms, generalized choroidal thinning was
observed in RP and Usher syndrome, but not
in Stargardt disease and cone-rod dystrophy.
Therefore, different pathophysiologic and blood
flow mechanisms may be implicated in each IRD,
which demands further cohort studies with special
consideration of choroidal blood flow as a potential
therapeutic target.
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